Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms
Louis S. Pymar(Cancer Research UK), Margaret A. Knowles(St James's University Hospital)
Cited by 55
Related Papers
Oncogenic FGFR3 gene fusions in bladder cancer
|Human Molecular Genetics|2012|378
Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo
|British Journal of Cancer|2010|178
FGFR1-Induced Epithelial to Mesenchymal Transition through MAPK/PLCγ/COX-2-Mediated Mechanisms
|PLoS ONE|2012|92
ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer
|Scientific Reports|2019|25